Prospective evaluation of GErmline mutations, Cancer outcome and Tissue biomarkers P.R.O.G.E.C.T.: A registry for patients with triple negative breast cancer and germline mutations

Brief Summary

Type:
Breast Cancer

Study Type:
Other

Phase:
N/A

ClinicalTrials.gov Identifier:
NCT02302742

Study #:
12614

Start Date:
Mar 21, 2011

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT02302742

View Complete Trial Details & Eligibility at ClinicalTrials.gov